FMI indicates the collagen peptide market was valued at USD 2.5 billion in 2025, increased to USD 2.8 billion in 2026, and is projected to reach USD 7.0 billion by 2036, reflecting a CAGR of 9.7% during 2026 to 2036. By segment, Bovine Collagen leads the Source Type category with a 54.3% share in 2026, while Type I Collagen Peptides dominate the Product Type segment with a 43.7% share in 2026.